Group 1 - Goldman Sachs has downgraded the net profit forecast for Jiu Xing Holdings (01836) for 2025 to 2027 by 9% to 16% and reduced the target price from HKD 18.2 to HKD 16.5, while maintaining a "Buy" rating due to the valuation not being overly high [1] - The sales revenue for Jiu Xing in Q4 2025 increased by 0.8% year-on-year, which is below Goldman Sachs' expectation of 4%, with OEM sales remaining flat due to shipment delays and average selling prices declining by 0.4% year-on-year [1] - The management indicated that profit margins will face multiple challenges in the second half of 2025, and it is expected that order channels will slow down in 2026 due to the ongoing impact of tariffs on the entire value chain [1]

Investment Rating - The investment rating for the company is "Accumulate" [6]. Core Insights - In Q4 2025, the company's revenue grew by 0.8% year-on-year, with shipment volume remaining flat. The company is positioned for investment in 2026, maintaining its commitment to return value to shareholders [2][10]. - The company has faced initial challenges in increasing production capacity in Indonesia and the Philippines, but has made progress. Efficiency in the Indonesian factory is expected to improve, reaching approximately 95% by January 2026 [10]. - The company plans to return up to $60 million in additional cash to shareholders annually through share buybacks and special dividends, alongside maintaining a typical payout ratio of 70% for 2025-2026 [10]. Financial Summary - Total revenue projections for the company are as follows: - 2024: $1,545 million - 2025E: $1,568 million - 2026E: $1,567 million - 2027E: $1,661 million - Net profit estimates are: - 2024: $171 million - 2025E: $138 million - 2026E: $151 million - 2027E: $165 million - The company’s PE ratios are projected to be: - 2024: 9.30 - 2025E: 11.53 - 2026E: 10.54 - 2027E: 9.62 [4][12].

Market Overview - The Hong Kong stock index opened high but closed lower, with the Hang Seng Index down 0.29% at 26,844.96 points, the Hang Seng Tech Index down 0.11% at 5,822.18 points, the National Enterprises Index down 0.5% at 9,220.81 points, and the Red Chip Index down 0.34% at 4,139.41 points [1] Company News - Tencent Holdings (00700.HK) repurchased 1.017 million shares for HKD 636 million at a price range of HKD 619-632 [2] - Xiaomi Group (01810.HK) repurchased 3.9 million shares for HKD 148 million at a price range of HKD 37.86-37.92 [3] - Six Fortune Group (00590.HK) reported a retail value increase of 26%, retail income increase of 17%, and same-store sales increase of 15% in Q3, exceeding expectations [3] - China Southern Airlines (01055.HK) reported a 11.89% increase in passenger capacity and a 19.28% increase in cargo capacity for December 2025 [6] Industry Insights - Tianfeng Securities noted that the Hong Kong stock market has a basis for short-term valuation recovery and sentiment improvement, but upward momentum may be constrained by high overseas interest rates [7] - The firm suggested a focus on technology and consumer sectors that are relatively undervalued [7] - According to Huatai Securities, the market is experiencing a shift towards a bullish sentiment, with historical data indicating a high probability of price increases following a period of panic [8] - Industry recommendations include prioritizing leading companies in the AI sector and exploring opportunities in insurance, banking, energy, and new consumption areas [8]

消息面上，九兴控股昨日公布，于2025年第四季度，集团未经审核综合收入同比上升0.8%至 3.886亿美 元；于2025年未经审核综合收入上升1.5%至15.678亿美元。鞋履制造业务方面，出货量于2025年第四季 度按年持平，于2025年全年则按年增加约3.8%，主要受运动类别以及公司正为之提升产量的新客户强 健的订单需求所带动。两段期间的平均售价皆有所下调，乃由于运动类别的增长所致，而其平均售价较 低。 九兴控股(01836)跌超5%，截至发稿，跌5.25%，报14.63港元，成交额8182.73万港元。 大和发布研报称，将九兴控股评级由"买入"降至"持有"，目标价由18港元下调至15.8港元。大和表示， 该公司第四季度业绩受到出货延迟及持续效率问题的影响，导致约25万双鞋的出货延迟至2026年初，预 计对2025年净利润造成200万美元的影响。大和预计公司2025年净利润将低于1.4亿美元，较市场预期的 1.56亿美元为低。2026年净利润预测为1.53亿美元，低于市场预期的1.67亿美元，主要考虑到三个新工 厂的开业亏损、两个中国运动鞋工厂可能缩减规模的遣散费用，以及工厂效率问题等因素。该行预期， 公 ...

智通财经APP获悉，九兴控股(01836)跌超5%，截至发稿，跌5.25%，报14.63港元，成交额8182.73万港 元。 消息面上，九兴控股昨日公布，于2025年第四季度，集团未经审核综合收入同比上升0.8%至 3.886亿美 元；于2025年未经审核综合收入上升1.5%至15.678亿美元。鞋履制造业务方面，出货量于2025年第四季 度按年持平，于2025年全年则按年增加约3.8%，主要受运动类别以及公司正为之提升产量的新客户强 健的订单需求所带动。两段期间的平均售价皆有所下调，乃由于运动类别的增长所致，而其平均售价较 低。 大和发布研报称，将九兴控股评级由"买入"降至"持有"，目标价由18港元下调至15.8港元。大和表示， 该公司第四季度业绩受到出货延迟及持续效率问题的影响，导致约25万双鞋的出货延迟至2026年初，预 计对2025年净利润造成200万美元的影响。大和预计公司2025年净利润将低于1.4亿美元，较市场预期的 1.56亿美元为低。2026年净利润预测为1.53亿美元，低于市场预期的1.67亿美元，主要考虑到三个新工 厂的开业亏损、两个中国运动鞋工厂可能缩减规模的遣散费用，以及工厂效率问题 ...

Major Events - Giant Bio (02367) received the Medical Device Registration Certificate from the National Medical Products Administration for its recombinant type I α1 collagen and sodium hyaluronate composite solution [1] - Jitu Express-W (01519) plans to subscribe for 226 million H shares of SF Holding and issue 822 million Class B shares to SF Holding [1] - Zijin Mining (02899) signed a cooperation and equity transfer agreement for the Shapingou Molybdenum Mine project [1] - Jiangxi Copper (00358) subsidiary signed an Investment Option Agreement with First Quantum for exploration cooperation in Kazakhstan's mining projects [1] - Derin Holdings (01709) received conditional approval from the CSRC for Derin Securities to provide virtual asset consulting services [1] - GAC Group (02238) subsidiary GAC Trumpchi received 100 million yuan in funding for industrial transformation and development [1] - Juteng International (03336) suspected of a cyber attack and has initiated a comprehensive investigation [1] Operating Performance - China Southern Airlines (01055) increased passenger capacity input by 11.89% year-on-year in December [1] - Air China (00753) reported a 10% year-on-year increase in passenger turnover in December [1] - China Eastern Airlines (00670) saw a 7.61% year-on-year increase in passenger turnover in December [1] - China Metallurgical Group (01618) new contract amount for 2025 is 1,113.6 billion yuan, a decrease of 10.8% year-on-year [1] - ZhongAn Online (06060) projected total original insurance premium income of approximately 35.643 billion yuan for 2025, an increase of 6.66% year-on-year [1] - China General Nuclear Power Corporation (01164) produced a total of 702.5 tons of natural uranium in the fourth quarter [1] - Jiuxing Holdings (01836) reported a 0.8% year-on-year increase in comprehensive income to 388.6 million USD in the fourth quarter [1] - Luoyang Molybdenum (03993) issued a profit warning, expecting annual net profit attributable to shareholders to be between 20 billion and 20.8 billion yuan, an increase of 47.80% to 53.71% year-on-year [1] - Chongqing Iron and Steel (01053) issued a profit warning, expecting a net loss of 2.5 billion to 2.8 billion yuan for 2025 [1] - Huiju Technology (01729) issued a profit warning, expecting annual net profit to increase by approximately 60% to 70% year-on-year [1]

格隆汇1月15日丨九兴控股(01836.HK)宣布，公司将于2026年3月19日(星期四)举行董事会会议，以(其中 包括)考虑及审议通过公司及其附属公司截至2025年12月31日止年度的全年业绩，及考虑派发末期股息 之建议。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 董事會會議通告 九興控股有限公司(「本公司」)董事(「董事」)會(「董事會」)宣佈，本公司將 於二零二六年三月十九日(星期四)舉行董事會會議，以(其中包括)考慮及審議通 過本公司及其附屬公司截至二零二五年十二月三十一日止年度的全年業績，及考 慮派發末期股息之建議。 於本公告日期，執行董事為陳立民先生、齊樂人先生、 Gillman Charles Christopher 先生及 蔣以民先生；及獨立非執行董事為 Bolliger Peter 先生、陳富強先生， BBS 、游朝堂先生、 尹倩儀女士及馬慧凡女士。 * 僅供識別 承董事會命 九興控股有限公司 主席 陳立民 香港，二零二六年一月十五日 ...

格隆汇1月15日丨九兴控股(01836.HK)发布公告，2025年第四季度，集团未经审核综合收入上升0.8%至 3.886亿美元(2024年：3.854亿美元)；截至2025年12月31日止十二个月，集团未经审核综合收入上升 1.5%至15.678亿美元(2024年：15.451亿美元)。 ...

鞋履制造业务方面，出货量于2025年第四季度按年持平，于2025年全年则按年增加约3.8%，主要受运 动类别以及公司正为之提升产量的新客户强健的订单需求所带动。两段期间的平均售价皆有所下调，乃 由于运动类别的增长所致，而其平均售价较低。 九兴控股(01836)公布，于2025年第四季度，集团未经审核综合收入同比上升0.8%至 3.886亿美元;于 2025年未经审核综合收入上升1.5%至15.678亿美元。 集团仍承诺于2025年及2026年除维持在通常水平约70%的派息率派付定期股息(包括末期股息及中期股 息)外，将通过结合股份回购及派付特别股息的方式向股东返还每年最多6,000万美元的额外现金。 在应对2025年上半年在印尼及菲律宾提产及扩充生产设施所遭遇的初步挑战方面，集团已取得进展。该 等努力所获得的经验将为集团日后新生产设施的试产与产能提升方面奠定关键基础，有关设施预计于 2026年下半年投产。 ...